GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Absci
Absci is a biotech company using artificial intelligence to accelerate the development of new protein drugs. Its stock price is a venture bet that its platform will dramatically reduce the time and cost of drug development.
Share prices of companies in the market segment - It med
Absci is a biotech company that combines artificial intelligence and synthetic biology to accelerate the development and discovery of new drugs. We classify it as part of the "IT in Medicine" sector. The chart below illustrates the dynamics of this cutting-edge field.
Broad Market Index - GURU.Markets
Absci is a biotech company that uses artificial intelligence and synthetic biology to accelerate the discovery and development of new drugs. As a pioneer, it is included in our GURU.Markets index. The chart below shows the overall market trend. Compare it with Absci's performance to assess the state of the sector.
Change in the price of a company, segment, and market as a whole per day
ABSI - Daily change in the company's share price Absci
Daily fluctuations in Absci, a company using AI to develop antibodies, reflect the high risks and expectations of the biotech sector. Change_co is an immediate reaction to partnership news. This metric is the basis for analysis in the computational biology sector on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - It med
Absci Corporation is a biotech company using AI to create drugs. This chart highlights the sector's extreme volatility. Comparing it to ABSCi's performance helps assess it as a high-risk asset at the intersection of biotech and artificial intelligence.
Daily change in the price of a broad market stock, index - GURU.Markets
Absci is a biotech company using artificial intelligence to accelerate drug discovery. This is a cutting-edge and highly speculative field at the intersection of biotech and AI. The chart below illustrates the high volatility typical of this sector, reflecting the enormous expectations and risks.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Absci
For Absci, which uses AI to develop antibodies, its year-over-year performance reflects investors' faith in a revolution in drug discovery. Its 12-month market cap change depends not on revenue, but on partnerships with major pharmaceutical companies and the achievement of technological milestones that demonstrate its platform can accelerate and reduce the cost of R&D.
Annual dynamics of market capitalization of the market segment - It med
Absci Corporation is a biotech company using AI to accelerate the discovery and development of new drugs. Its technology platform is its key advantage. The chart shows how the market views its innovative, yet capital-intensive, approach to drug development compared to traditional biotech.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Absci, with its AI-powered drug discovery platform, is a hybrid of biotech and IT. Its stock price is a speculative bet that its technology could revolutionize pharmaceuticals. The chart isn't tied to economics, but rather reflects investors' faith in one of the most ambitious ideas at the intersection of two industries.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Absci
The valuation of Absci, a company in the field of generative AI for drug discovery, is speculative. The monthly fluctuations on the chart do not reflect revenue, but rather news about partnerships with major pharmaceutical companies and technological breakthroughs in its platform.
Monthly dynamics of market capitalization of the market segment - It med
Absci Corporation is a generative AI company that uses its platform to discover and develop next-generation biologics. Its sector dynamics, shown in the chart, reflect its belief in the convergence of biotechnology and AI. Against this backdrop, one can appreciate how its unique technology, which enables in silico antibody design, can accelerate drug discovery.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Absci uses AI to create drugs, placing it at the intersection of biotech and technology. Its shares are extremely volatile, reacting to both industry news and its own scientific announcements. The chart illustrates how a company can simultaneously follow the general AI hype and completely ignore the market after data releases.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Absci
Absci uses artificial intelligence to accelerate drug development. Its weekly stock price is a speculative bet on a revolution in pharmaceuticals. News of partnerships with major pharmaceutical companies and technological breakthroughs are generating strong reactions.
Weekly dynamics of market capitalization of the market segment - It med
Absci, like the entire AI biotech sector, reacts weekly to overall investor sentiment toward innovation and news of major pharmaceutical partnerships. This chart will show how this early-stage company is performing within the context of the overall trend at the intersection of AI and medicine.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Absci is using AI to develop drugs, betting on a revolution in biotech. The chart will show how its stock performance is disconnected from the broader market, living in a world of news about technological breakthroughs and partnerships, ignoring general economic trends.
Market capitalization of the company, segment and market as a whole
ABSI - Market capitalization of the company Absci
The Absci Corporation chart shows a bet on the use of artificial intelligence in drug development. This company's market cap reflects investors' belief that its AI-powered antibody creation and screening platform can dramatically speed up and reduce the cost of developing new drugs.
ABSI - Share of the company's market capitalization Absci within the market segment - It med
Absci Corporation is seeking to capture market share by using generative AI and synthetic biology to accelerate the discovery of new antibodies and drugs. Its capitalization is a bet that its platform will revolutionize R&D.
Market capitalization of the market segment - It med
Absci is using AI to accelerate drug development. How big is this revolution? The chart below shows the overall market capitalization of the medical IT sector. Its dynamics reflect how artificial intelligence and synthetic biology are converging to fundamentally transform the pharmaceutical industry.
Market capitalization of all companies included in a broad market index - GURU.Markets
The Absci chart shows an ambitious attempt to combine artificial intelligence and synthetic biology to create new drugs. The company's market cap reflects a venture bet on its platform, which promises to radically accelerate antibody development. This chart shows how the market values the future of bioengineering.
Book value capitalization of the company, segment and market as a whole
ABSI - Book value capitalization of the company Absci
Absci, which uses AI to develop antibodies, derives its book value from its physical foundation: automated labs, data analysis equipment, and bioreactors. The chart below shows how the company has invested in creating this unique physical platform to accelerate drug discovery.
ABSI - Share of the company's book capitalization Absci within the market segment - It med
Absci Corporation combines AI and biotechnology. Its tangible assets are unique laboratories where robotic systems and synthetic biology methods are used to create new drugs. The chart shows the share of this advanced, automated R&D infrastructure the company controls.
Market segment balance sheet capitalization - It med
Absci is an AI-powered drug discovery company. Pharmaceuticals, as the chart shows, are capital-intensive. Absci is a knowledge-intensive, asset-light company. Its assets are not factories, but laboratories and an AI platform for antibody creation.
Book value of all companies included in the broad market index - GURU.Markets
Absci's assets are unique laboratories that combine artificial intelligence and synthetic biology to create new drugs. The chart shows how the company built this cutting-edge physics platform at the intersection of IT and biotechnology.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Absci
Absci's assets are unique laboratories at the intersection of AI and biotech. Their market valuation is a pure bet on their ability to revolutionize drug discovery. The chart is a visualization of this futuristic hope.
Market to book capitalization ratio in a market segment - It med
Absci is a biotech company using artificial intelligence to accelerate drug development. Its value lies in its platform and data. The chart shows how its market capitalization, based on its technology's potential, is many times greater than its current assets.
Market to book capitalization ratio for the market as a whole
Absci is a biotech company using AI to accelerate drug discovery. Its current valuation, relative to the average, is a pure bet on its technology platform. Investors believe its approach can revolutionize the pharmaceutical industry, and this belief is unrelated to its current tangible assets.
Debts of the company, segment and market as a whole
ABSI - Company debts Absci
Absci uses artificial intelligence and synthetic biology to accelerate drug discovery. This chart shows the company's financial strategy at the intersection of tech and biotech. It is raising significant equity capital to build its platform and partner with major pharmaceutical companies.
Market segment debts - It med
Absci uses artificial intelligence to accelerate the discovery and development of new biologics. This is a cutting-edge but capital-intensive field at the intersection of biotech and AI. This chart shows how the company's debt policy reflects its funding needs to develop its platform and prove its effectiveness in partnership with pharmaceutical companies.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Absci
Absci is a biotech company using artificial intelligence to accelerate drug discovery. This is a cutting-edge but capital-intensive field. This chart shows the extent to which the company finances its innovations with debt. It reflects its financial risk and reliance on external capital as it seeks to commercialize its platform.
Market segment debt to market segment book capitalization - It med
Absci uses artificial intelligence to accelerate drug discovery. This chart shows the biotech sector's debt load. It's an indicator of the company's ability to finance its capital-intensive research and development of a platform that could revolutionize the pharmaceutical industry.
Debt to book value of all companies in the market
Absci is a biotech company using artificial intelligence to accelerate drug development. This is a cutting-edge and capital-intensive field. This chart of total market debt shows how willing investors and lenders are to finance companies with revolutionary but unproven business models, which is important for Absci's future.
P/E of the company, segment and market as a whole
P/E - Absci
Absci is a biotech company that uses artificial intelligence and synthetic biology to accelerate the discovery and development of new antibody-based drugs. This chart reflects investors' belief in a revolution in R&D. Its performance is speculative and depends on partnerships with major pharmaceutical companies.
P/E of the market segment - It med
Absci is a biotech company that uses artificial intelligence and synthetic biology to accelerate the discovery and development of new protein-based drugs, such as antibodies. This chart shows the average valuation for the IT healthcare sector, reflecting how investors view companies using AI to revolutionize drug discovery.
P/E of the market as a whole
Absci is a biotech company using artificial intelligence to accelerate drug discovery. Its valuation is a pure bet on its technology platform and is unrelated to the general economic cycles reflected in this chart. Its fate is decided in the lab and depends on its ability to prove the effectiveness of its approach.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Absci
Absci Corporation is a biotech company using artificial intelligence and synthetic biology to accelerate the discovery and development of new drugs. This chart reflects the high expectations for its innovative platform. The company's valuation is a venture capital bet that its technology can truly revolutionize pharmaceutical R&D.
%20P%2FE%20Absci&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Absci&v=1772551249438 "Chart of the company's future (projected) P/E Absci")
Future (projected) P/E of the market segment - It med
Absci combines artificial intelligence and synthetic biology to accelerate drug discovery and development. This chart reflects investor confidence in its breakthrough technology platform. Comparing its future revenue forecasts with the industry reveals the premium the market is willing to pay for its potential to transform the pharmaceutical industry.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20It%20med&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-It-med&v=1772551249460 "Future (projected) P/E graph of the market segment - It med")
Future (projected) P/E of the market as a whole
Absci is a biotech company that uses artificial intelligence and synthetic biology to accelerate the discovery and development of new drugs. This is a cutting-edge and risky field. This general risk appetite chart measures how willing investors are to invest in platform companies with long-term potential but no current revenue.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772551249474 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Absci
Absci Corporation is a biotechnology company using artificial intelligence and synthetic biology to accelerate the discovery and development of new drugs. Its current financial results reflect investments in its platform. Future profits depend on partnerships with pharmaceutical companies and the success of its technological approach.
Profit of companies in the market segment - It med
Absci Corporation is at the intersection of AI and biotechnology, using its platform to accelerate the discovery of new antibody-based drugs. The company promises to revolutionize pharmaceutical R&D. The healthcare IT profitability chart shows how willing the pharmaceutical industry is to implement and pay for cutting-edge technologies to improve the efficiency of its research.
Overall market profit
Absci is a biotech company that uses artificial intelligence and synthetic biology to accelerate the discovery and development of new drugs. Its platform has the potential to dramatically reduce the time and cost of bringing drugs to market. Absci is at the intersection of IT and biotech, and its success reflects how technology is transforming the pharmaceutical industry.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Absci
Absci is a biotech company using artificial intelligence to accelerate drug discovery. This chart reflects high, yet speculative, expectations for its platform. Future profits depend on partnerships with major pharmaceutical companies.
%20profit%20of%20the%20company%20Absci&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Absci&v=1772551249578 "Graph of future (projected) profit of the company Absci")
Future (predicted) profit of companies in the market segment - It med
Absci Corporation uses artificial intelligence and synthetic biology to accelerate the discovery and development of new drugs. This chart shows forecasts for the biotech sector. It helps assess how the company's revolutionary platform can transform pharmaceutical R&D and its prospects in this innovative industry.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20It%20med&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-It-med&v=1772551249611 "Graph of future (predicted) profits of companies in a market segment - It med")
Future (predicted) profit of the market as a whole
The trajectory on this chart shows the expectations for a biotech company using artificial intelligence to develop drugs. Absci's profit forecast hinges on partnerships with major pharmaceutical companies and the success of its platform. This is a bet on revolutionizing the drug discovery process.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772551249636 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Absci
Absci uses artificial intelligence to accelerate drug development. The company has virtually no traditional revenue. This chart shows a valuation based solely on the potential of its AI platform. It's a bet that its technology will revolutionize pharmaceuticals.
P/S market segment - It med
Absci is a biotech company using artificial intelligence and synthetic biology to accelerate the discovery and development of new drugs. Revenue is generated through partnerships with pharmaceutical companies. This chart shows the average valuation in the sector, reflecting how investors assess the potential of Absci's platform to revolutionize R&D and generate future revenue.
P/S of the market as a whole
Absci is a biotech company that uses artificial intelligence and synthetic biology to accelerate the discovery and development of new drugs. Its revenue comes from partnerships with pharmaceutical companies. This chart, which displays average revenue estimates, helps Absci understand the market premium the company is willing to pay for a platform technology that has the potential to transform an entire industry.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Absci
Absci is a biotech company that uses artificial intelligence and synthetic biology to accelerate the discovery and development of new drugs. This chart reflects investor confidence in its platform. It shows the market's estimate of its future revenue, which depends on partnerships with major pharmaceutical companies and the success of its technology.
%20P%2FS%20Absci&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Absci&v=1772551249952 "The graph of the company's future (projected) P/S Absci")
Future (projected) P/S of the market segment - It med
Absci uses artificial intelligence and synthetic biology to accelerate the discovery and development of new drugs. This chart compares market expectations for its future revenue with other healthcare technology companies. This valuation reflects investor confidence in its breakthrough technology platform and its partnerships with pharmaceutical companies.
%20P%2FS%20market%20segment%20graph%20-%20It%20med&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-It-med&v=1772551249989 "Future (projected) P/S market segment graph - It med")
Future (projected) P/S of the market as a whole
Absci is a biotech company that uses artificial intelligence to accelerate the drug discovery process. Its platform promises to reduce research time and costs. Absci's potential to revolutionize R&D is part of the overall optimism about how AI will transform pharmaceuticals, as reflected in this chart.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772551250015 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Absci
Absci has created an AI-powered platform to accelerate the discovery and development of new biologics. While in development, its revenue may come from partnerships with pharmaceutical companies. This chart shows the revenue from these deals, demonstrating the industry's adoption of its technology.
Sales of companies in the market segment - It med
Absci Corporation is at the intersection of artificial intelligence and synthetic biology, creating a platform for the accelerated discovery and development of new protein drugs. Its technology promises to revolutionize biopharmaceutical development. This chart shows total sales in the sector, illustrating how AI and biotechnology are converging to transform the pharmaceutical industry.
Overall market sales
Absci is a biotech company using artificial intelligence to accelerate the discovery and development of new antibody-based drugs. This overall economic activity graph is important for Absci through investments. Funding for breakthrough platforms like the one Absci is building depends on overall market health and risk appetite.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Absci
Absci is a biotech company that uses artificial intelligence and synthetic biology to accelerate the discovery and development of new antibody-based drugs. This chart reflects analysts' expectations for demand for its innovative platform from pharmaceutical companies seeking to reduce R&D time and costs.
%20sales%20of%20the%20company%20Absci&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Absci&v=1772551250144 "Schedule of future (projected) sales of the company Absci")
Future (projected) sales of companies in the market segment - It med
Absci Corporation uses artificial intelligence and synthetic biology to accelerate drug development. This chart shows projected revenues for the entire biotech sector. While it reflects general expectations for R&D investment, Absci prioritizes partnerships with major pharmaceutical companies to leverage its platform.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20It%20med&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-It-med&v=1772551250170 "Schedule of future (projected) sales of companies in the market segment - It med")
Future (projected) sales of the market as a whole
Absci is a biotech company that uses artificial intelligence to accelerate the discovery and development of new drugs. Its business model is based on partnerships with major pharmaceutical companies. This graph, reflecting the investment climate, influences the willingness of pharma giants to invest in innovative platforms like the one Absci offers.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772551250208 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Absci
Absci uses artificial intelligence to accelerate drug development. The graph for a research-stage company like this shows not profit, but rather the efficiency of cost management. It illustrates how the company uses capital to develop its platform, which should eventually generate revenue from partnerships with pharmaceutical giants.
Market segment marginality - It med
Absci combines artificial intelligence and synthetic biology to accelerate drug discovery. It's at the cutting edge of biotechnology. This chart depicts the company's operational structure during its intensive research phase, highlighting its significant investment in building a platform that could revolutionize the pharmaceutical industry.
Market marginality as a whole
Absci is a biotech company using artificial intelligence to accelerate drug discovery. Its future profitability depends on the success of its platform and partnerships with pharmaceutical companies. This total market profitability chart serves as a contrast to cutting-edge science, where Absci aims to revolutionize the labor-intensive drug discovery process with AI.
Employees in the company, segment and market as a whole
Number of employees in the company Absci
Absci is a biotech company that uses artificial intelligence and synthetic biology to accelerate drug discovery and development. This chart shows its growing team of scientists and AI specialists. This increase reflects investments in its unique platform and partnerships with major pharmaceutical companies.
Share of the company's employees Absci within the market segment - It med
This chart illustrates Absci Corporation's innovative approach. The company's biotech workforce is focused on using artificial intelligence and synthetic biology to accelerate the discovery and development of new antibody-based drugs. This team of data scientists and engineers strives to make pharmaceutical R&D faster and more predictable.
Number of employees in the market segment - It med
Absci Corporation is a biotech company using artificial intelligence and synthetic biology to accelerate drug discovery. The integration of AI into R&D is a revolutionary trend. This graph illustrates how the intersection of biotech and IT is giving rise to new approaches and professions that require specialists with competencies in both fields.
Number of employees in the market as a whole
Absci Corporation uses artificial intelligence to accelerate drug discovery. Its business is revolutionizing biotechnology. Its success depends on the effectiveness of its platform, not on the economic cycles shown in this chart. The company aims to make drug discovery faster and cheaper.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Absci (ABSI)
Absci is a biotech company using artificial intelligence to accelerate drug discovery. This chart demonstrates the synergy between AI and biotech. Its astronomical market cap per employee reflects investors' belief that its platform has the potential to revolutionize the pharmaceutical industry, not its current revenue.
%20of%20the%20company%20Absci%20(ABSI)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Absci-ABSI&v=1772551250479 "Chart of market capitalization per employee (in thousands of dollars) of the company Absci (ABSI)")
Market capitalization per employee (in thousands of dollars) in the market segment - It med
Absci uses artificial intelligence to accelerate drug discovery. In the bio-AI sector, this metric reflects the market's assessment of the technology's revolutionary potential. The chart illustrates the enormous value investors place on the platform's ability to shave years and billions of dollars off drug development time.
%20by%20market%20segment%20-%20It%20med&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-It-med&v=1772551250494 "Market capitalization per employee (in thousands of dollars) by market segment - It med")
Market capitalization per employee (in thousands of dollars) for the overall market
Absci Corp. is a biotech company using artificial intelligence to accelerate drug development. This chart reflects investors' faith in its technology platform. The company's very high valuation per employee reflects a bet that its AI approach can radically reduce the time and cost of developing new drugs.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772551250539 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Absci (ABSI)
Absci (ABSI) is a biotech company using AI and synthetic biology to "design" new drugs (antibodies). It's an R&D platform. The company is not profitable. This chart reflects the R&D budget burn rate. Each employee (scientist, AI engineer) is working to create a platform that will *in the future* accelerate drug discovery.
%20Chart%20Absci%20(ABSI)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Absci-ABSI&v=1772551250567 "Company Profit Per Employee (in thousands of dollars) Chart Absci (ABSI)")
Profit per employee (in thousands of dollars) in the market segment - It med
Absci is a biotech company using AI and synthetic biology to accelerate the discovery of new drugs (antibodies). It's a "TechBio" company. This chart shows the loss per employee during the R&D phase. It serves as a benchmark for assessing how intensively the company is investing in its platform and scientists to revolutionize R&D, compared to other biotechs.
%20in%20the%20market%20segment%20-%20It%20med&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-It-med&v=1772551250593 "Chart of profit per employee (in thousands of dollars) in the market segment - It med")
Profit per employee (in thousands of dollars) for the market as a whole
Absci (ABSI) is a biotech company using artificial intelligence (AI) and synthetic biology to develop and discover new drugs (antibodies). It's an R&D platform. This chart (deeply loss-making) shows the cost of their innovation. Each employee (scientist, data scientist) is very expensive. Investors expect partnerships with Big Pharma to generate revenue that will eventually recoup these costs.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772551250650 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Absci (ABSI)
Absci uses artificial intelligence to accelerate the discovery and development of antibodies and other biologics. This chart reflects the company's activities at the intersection of biotechnology and AI. Future revenue per employee will depend on the success of partnerships with pharmaceutical companies.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Absci-ABSI&v=1772551250693 "Sales chart per company employee Absci (ABSI)")
Sales per employee in the market segment - It med
Absci is a biotech company using AI and synthetic biology to accelerate drug development. This chart shows the average revenue per employee in the segment. For an R&D-stage company providing platform services, it compares their productivity (through partnerships) to sector benchmarks.
Sales per employee for the market as a whole
Absci is a biotech company using AI and synthetic biology to accelerate the discovery of new drugs (antibodies). They don't sell drugs, but rather act as an R&D partner for Big Pharma. This metric reflects how their platform and team of scientists generate revenue from partnerships and licensing.
Short shares by company, segment and market as a whole
Shares shorted by company Absci (ABSI)
Absci is a biotech company using AI to develop and discover new drugs (antibodies). The bearish sentiment seen in this chart reflects skepticism about the hype surrounding AI in biotech. The bearish sentiment indicates that the company is unprofitable and its technology has not yet proven its commercial viability.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Absci-ABSI&v=1772551250703 "Short Shares Chart for the Company Absci (ABSI)")
Shares shorted by market segment - It med
Absci is a biotech company using AI and synthetic biology to design and discover new drugs (antibodies). This chart reflects the overall sentiment in the sector. It reflects investor skepticism toward "platform" biotech companies that promise a revolution in R&D but don't yet have approved drugs.
Shares shorted by the overall market
Absci (ABSI) uses AI to develop and discover new biologics. It's one of the most speculative sectors: "AI" plus "biotech." This chart measures overall risk aversion. When it rises, investors panic and dump stocks whose value is based on the distant future, not current profits. ABSI is a perfect candidate for a sell-off.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Absci (ABSI)
Absci is a biotech company using AI and synthetic biology to accelerate the discovery of new drugs (antibodies). It's a highly speculative bet on AI in R&D. This chart measures the level of hype. It shows when euphoria about AI's potential (overbought) or doubts about the technology (oversold) reach a peak.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Absci-ABSI&v=1772551250749 "RSI 14 indicator chart for the company's stock Absci (ABSI)")
RSI 14 Market Segment - It med
Absci is a biotech company that uses AI and synthetic biology to discover and develop new drugs (primarily antibodies). Their "Integrated Drug Creation" platform accelerates R&D. This chart reflects the overall sentiment in the AI and biotech sectors. It helps assess whether the hype surrounding AI is overheated.
RSI 14 for the overall market
Absci (ABSI) uses AI to discover drugs. This chart is an indicator of hype and capital availability. In the euphoria, investors are ready to fund the "future" (AI + biotech). In a panic, they flee unprofitable R&D projects, and the cash spigot for Absci, which is burning through hundreds of millions, could be shut off.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast ABSI (Absci)
Absci (ABSI) uses artificial intelligence and synthetic biology to accelerate drug discovery (specifically, antibodies). This chart shows the average target price. It reflects analysts' speculative assessment of the potential of this AI platform and its ability to partner with major pharma.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-ABSI-Absci&v=1772551250755 "A chart showing analyst consensus forecasts for the expected stock price. ABSI (Absci)")
The difference between the consensus estimate and the actual stock price ABSI (Absci)
Absci is a biotech company that uses generative AI (GenAI) to create drugs. Its platform designs new proteins and antibodies in silico, rather than searching for them in nature. This is an R&D bet. This chart shows the difference between the consensus forecast and the price, reflecting analysts' confidence in this futuristic platform.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-ABSI-Absci&v=1772551250768 "A chart showing the difference between the consensus forecast and the actual stock price. ABSI (Absci)")
Analyst consensus forecast for stock prices by market segment - It med
Absci—a "TechBio" company that uses AI and synthetic biology to "design" new drugs (antibodies) on a computer rather than in a lab. This chart shows the general expectations of analysts in the medical IT sector. It reflects whether experts believe AI can truly accelerate and reduce the cost of pharmaceutical R&D.
Analysts' consensus forecast for the overall market share price
Absci is a biotech company that combines AI and synthetic biology to "design" new drugs (antibodies). It's an AI-powered "R&D factory." This chart shows overall market sentiment. For Absci, as a "deep tech" startup, it's important to understand how the overall risk appetite (sentiment) impacts their ability to fund their revolutionary, yet expensive, platform. (349)
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Absci
Absci is generative AI for biotech. Their platform uses AI to design (in silico) and create new protein drugs (antibodies) from scratch. It's OpenAI for medicine. This chart represents pure R&D. It likely reflects not revenue, but the market's faith in their AI platform, their R&D milestones, and their partnerships with pharma giants (Merck, AstraZeneca).
AKIMA Market Segment Index - It med
Absci (ABSI) is an AI biotech company (like Recursion); the company combines AI and synthetic biology (laboratory experiments) into a single platform for accelerated drug discovery and development (antibody). This composite metric evaluates R&D. The graph shows the average value for the segment. This is a benchmark: how does this futuristic (AI) R&D platform (ABSI) differentiate itself from the average pharma company?
The AKIM Index for the overall market
Absci is a company using generative AI to create new biologics. It's the intersection of technology and biology. This chart, which reflects the market average, is an indicator of risk appetite. It provides a macro backdrop that's critical for assessing the prospects of this innovative drug discovery platform.
